MyAccuray: Accuray Synchrony® Raises the Bar in AAPM MArkerless Lung Target Tracking Challenge
Delivering effective and safe lung cancer stereotactic body radiation therapy (SBRT) requires technology that can account for lung tumor motion. Both fiducial-based and markerless tracking algorithms currently exist, with markerless being a focus of innovation, investment and research in the field. These tracking algorithms, however, have not been benchmarked using a common, prospective measurement methodology. The American Association of Physicists in Medicine (AAPM) designed the MArkerless Lung Target Tracking CHallenge (MATCH), an AAPM Grand Challenge, to compare the precision and accuracy of existing markerless tracking algorithms.
TomoTherapy® based dose-escalated radiation therapy for painful bone metastases using the Scan-Plan-QA-Treat workflow
In this webinar, Drs. Muller and Wijesooriya will discuss their experience with same day simulation, planning, and treatment of painful osseous metastases with dose escalated radiation therapy using the TomoTherapy platform. They will also discuss the prospective trials, and the workflow performed at the University of Virginia. The session will be moderated by Dr. Paul Read.
Total Marrow Irradiation with TomoTherapy®: Redefining the Role of Radiation Therapy in Hematopoietic Cell Transplantation
In this webinar Dr Wong and Dr Liu will provide an overview of the Total Marrow Irradiation technique on TomoTherapy and outline their 15 year experience of treating patients with this approach.
TomoTherapy® for Breast Cancer in a Clinical Practice
In this webinar we will present both clinical and technical aspects of our hypofractationed approach to whole breast, partial breast and breast reirradation using TomoTherapy®. We will describe how we select patient for TomoDirect™ and TomoHelical™ modalities, and will share details of our Phase I/II clinical trial on single fraction ablative preoperative radiation treatment for early-stage breast cancer.
Russian Experience of using Helical TomoTherapy for Total Body Irradiation in Wide Heterogenic Cohort of 262 Pediatric Patients with Hematological Malignancies
Dmitry Rogachev National Research Center in Russia is a leading specialized center in the area of pediatric hematology/oncology and immunology. In this webinar we will share our experience with Helical TomoTherapy for the application of Total Body Irradiation in a wide heterogenic cohort of pediatric patients with hematological malignancies. We have treated 262 pediatric patients since this approach was introduced in our center in 2014.
Comprehensive Performance Tests of the First Clinical Real-Time Motion Tracking and Compensation System Using MLC and Jaws
Dr. Chen is an Assistant Professor and the Clinical Director of Medical Physics in the Department of Radiation Oncology at Medical College of Wisconsin.
Clinical Outcomes and Dosimetric Study of Hypofractionated Helical TomoTherapy® in Breast Cancer Patients
Dr. Imjai Chitapanarux is professor and Deputy Head of the Department of Radiology at Faculty of Medicine, Chiang Mai University, Thailand.
What Does the TomoTherapy® System Bring to Pediatric Treatment Challenges?
View Recorded Webinar Prof. Anne Laprie, M.D., Ph.D. – IUCT Oncopole, Toulouse, France Moderator: Catherine DeJean, Ph.D. – Centre Antoine Lacassagne – Nice, France Professor Anne Laprie is a radiation oncologist specialized in pediatric and AYA radiation oncology at the Institut Universitaire du Cancer de Toulouse- Oncopole. She is a user of the TomoTherapy® System in pediatric cases, particularly […]
An overview of the Medicare Radiation Oncology Alternative Payment Model 2020 Proposed Rule
Shawn Prince, MBA is the Senior Director, Patient Access at Accuray Incorporated.
Role of the TomoTherapy® System in the Treatment of Rectal Cancer
Berardino De Bari, M.D. is a radiation oncologist working in the radiation oncology dpt of Besançon (France). He has an academic position as Assistant Professor of the University of Bourgogne – Franche Comté (France) and of the University of Lausanne (Switzerland). His clinical and scientific interests are genitourinary and gastrointestinal cancers. He is a fellow of the European Society of Radiation Oncology (ESTRO) and he is teacher for ESTRO and for the International Atomic Energy Agency (IAEA). He is co-author of more than 95 articles and he is regularly invited as chair or speaker in national and international meetings.
